HDM2004 is a selective, orally active, blood-brain barrier-penetrant HPK1 inhibitor with an IC 50 of 1.89 nM. HDM2004 exhibits anticancer activity against colon cancer . HDM2004 shows synergistic activity when combined with anti- PD-L1 in syngeneic mouse models. HDM2004 can be used for the research of colon cancer .
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Colorectal Cancer | Products > Disease Areas > Digestive System Cancer | Products > Signaling Pathways > MAPK/ERK Pathway | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > MAP4K
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.